Amgen 1st-quarter profit boosted by drug price rises, lower R&D

April 21, 2015 8:24 PM

3 0

April 21 (Reuters) - Amgen Inc reported higher first-quarter earnings on Tuesday, driven by price increases for its biggest-selling drugs, as well as lower spending on research and development.

The Thousand Oaks, California, drugmaker posted a quarterly net profit of $1.62 billion, or $2.11 per share, a 51 percent increase from $1.07 billion, or $1.40 per share, a year earlier.

Also read: Deutsche Bank Posts Unexpected Profit on Lower Overhaul Costs

Read more

To category page